
Sign up to save your podcasts
Or
Another day, another downgrade for Apple’s stock – the second this week. The shares are down more than 5% to start the year, as concerns over iPhone demand grow. We’ll speak to the analyst behind the latest call. Plus, Eli Lilly is taking weight-loss drugs directly to the consumer, setting up a new service to help patients get telehealth prescriptions. We’ll ask a medical doctor about the potential implications.
4.3
1515 ratings
Another day, another downgrade for Apple’s stock – the second this week. The shares are down more than 5% to start the year, as concerns over iPhone demand grow. We’ll speak to the analyst behind the latest call. Plus, Eli Lilly is taking weight-loss drugs directly to the consumer, setting up a new service to help patients get telehealth prescriptions. We’ll ask a medical doctor about the potential implications.
4,085 Listeners
1,359 Listeners
238 Listeners
3,195 Listeners
148 Listeners
328 Listeners
68 Listeners
153 Listeners
2,142 Listeners
600 Listeners
550 Listeners
20 Listeners
195 Listeners
404 Listeners
302 Listeners
117 Listeners
795 Listeners
179 Listeners
60 Listeners
161 Listeners
33 Listeners
11 Listeners
9 Listeners
261 Listeners
9 Listeners